Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF33B | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | C2orf47 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | SARDH | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | NCOA5 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | DCAF16 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | LGI4 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | ZNF320 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | NPTXR | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | GDF11 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | PRR12 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |